TURKU, FINLAND / ACCESS Newswire / January 13, 2026 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN), a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, announces tod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback